Optimized vinpocetine-loaded vitamin E D-α-tocopherol polyethylene glycol 1000 succinate-alpha lipoic acid micelles as a potential transdermal drug delivery system: in vitro and ex vivo studies
Osama AA Ahmed,1,2 Khalid M El-Say,1,3 Bader M Aljaeid,1 Shaimaa M Badr-Eldin,1,4 Tarek A Ahmed1,3 1Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia; 2Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Minia Universi...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/927ac8e92e704923aadabbfecaf394fa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:927ac8e92e704923aadabbfecaf394fa |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:927ac8e92e704923aadabbfecaf394fa2021-12-02T07:31:18ZOptimized vinpocetine-loaded vitamin E D-α-tocopherol polyethylene glycol 1000 succinate-alpha lipoic acid micelles as a potential transdermal drug delivery system: in vitro and ex vivo studies1178-2013https://doaj.org/article/927ac8e92e704923aadabbfecaf394fa2018-12-01T00:00:00Zhttps://www.dovepress.com/optimized-vinpocetine-loaded-vitamin-e-d-alpha-tocopherol-polyethylene-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Osama AA Ahmed,1,2 Khalid M El-Say,1,3 Bader M Aljaeid,1 Shaimaa M Badr-Eldin,1,4 Tarek A Ahmed1,3 1Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia; 2Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Minia University, Minia, Egypt; 3Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt; 4Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt Background: Vinpocetine (VNP), a semisynthetic natural product, is used as a vasodilator for cerebrovascular and age-related memory disorders. VNP suffers from low oral bioavailability owing to its low water solubility and extensive first-pass metabolism. This work aimed at utilizing D-α-tocopherol polyethylene glycol 1000 succinate (TPGS) and alpha lipoic acid (ALA) to develop efficient micellar system for transdermal delivery of VNP. Materials and methods: VNP-TPGS-ALA micelles were prepared, characterized for particle size using particle size analyzer, and investigated for structure using transmission electron microscope. Optimization of VNP-TPGS-ALA micelles-loaded transdermal films was performed using Box–Behnken experimental design. The investigated factors were percentage of ALA in TPGS (X1), citral concentration (X2), and propylene glycol concentration (X3). Elongation percent (Y1), initial permeation after 2 hours (Y2), and cumulative permeation after 24 hours (Y3) were studied as responses. Results: Statistical analysis revealed optimum levels of 16.62%, 3%, and 2.18% for X1, X2, and X3, respectively. Fluorescent laser microscopic visualization of skin penetration of the optimized transdermal film revealed marked widespread fluorescence intensity in skin tissue after 0.5, 2, and 4 hours compared with raw VNP transdermal film formulation, which indicated enhancement of VNP skin penetration. Conclusion: The obtained results highlighted the potentiality of VNP nanostructure-based films for controlling the transdermal permeation of the drug and improving its effectiveness. Keywords: bioavailability, box behnken design, citral, fluorescent laser microscope, nanostructured-based films, permeationAhmed OAAEl-Say KMAljaeid BMBadr-Eldin SMAhmed TADove Medical PressarticleAlpha lipoic acidBioavailabilityBox Behnken designD-α-Tocopherol polyethylene glycol succinateOptimizationTransdermal filmsMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 14, Pp 33-43 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Alpha lipoic acid Bioavailability Box Behnken design D-α-Tocopherol polyethylene glycol succinate Optimization Transdermal films Medicine (General) R5-920 |
spellingShingle |
Alpha lipoic acid Bioavailability Box Behnken design D-α-Tocopherol polyethylene glycol succinate Optimization Transdermal films Medicine (General) R5-920 Ahmed OAA El-Say KM Aljaeid BM Badr-Eldin SM Ahmed TA Optimized vinpocetine-loaded vitamin E D-α-tocopherol polyethylene glycol 1000 succinate-alpha lipoic acid micelles as a potential transdermal drug delivery system: in vitro and ex vivo studies |
description |
Osama AA Ahmed,1,2 Khalid M El-Say,1,3 Bader M Aljaeid,1 Shaimaa M Badr-Eldin,1,4 Tarek A Ahmed1,3 1Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia; 2Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Minia University, Minia, Egypt; 3Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt; 4Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt Background: Vinpocetine (VNP), a semisynthetic natural product, is used as a vasodilator for cerebrovascular and age-related memory disorders. VNP suffers from low oral bioavailability owing to its low water solubility and extensive first-pass metabolism. This work aimed at utilizing D-α-tocopherol polyethylene glycol 1000 succinate (TPGS) and alpha lipoic acid (ALA) to develop efficient micellar system for transdermal delivery of VNP. Materials and methods: VNP-TPGS-ALA micelles were prepared, characterized for particle size using particle size analyzer, and investigated for structure using transmission electron microscope. Optimization of VNP-TPGS-ALA micelles-loaded transdermal films was performed using Box–Behnken experimental design. The investigated factors were percentage of ALA in TPGS (X1), citral concentration (X2), and propylene glycol concentration (X3). Elongation percent (Y1), initial permeation after 2 hours (Y2), and cumulative permeation after 24 hours (Y3) were studied as responses. Results: Statistical analysis revealed optimum levels of 16.62%, 3%, and 2.18% for X1, X2, and X3, respectively. Fluorescent laser microscopic visualization of skin penetration of the optimized transdermal film revealed marked widespread fluorescence intensity in skin tissue after 0.5, 2, and 4 hours compared with raw VNP transdermal film formulation, which indicated enhancement of VNP skin penetration. Conclusion: The obtained results highlighted the potentiality of VNP nanostructure-based films for controlling the transdermal permeation of the drug and improving its effectiveness. Keywords: bioavailability, box behnken design, citral, fluorescent laser microscope, nanostructured-based films, permeation |
format |
article |
author |
Ahmed OAA El-Say KM Aljaeid BM Badr-Eldin SM Ahmed TA |
author_facet |
Ahmed OAA El-Say KM Aljaeid BM Badr-Eldin SM Ahmed TA |
author_sort |
Ahmed OAA |
title |
Optimized vinpocetine-loaded vitamin E D-α-tocopherol polyethylene glycol 1000 succinate-alpha lipoic acid micelles as a potential transdermal drug delivery system: in vitro and ex vivo studies |
title_short |
Optimized vinpocetine-loaded vitamin E D-α-tocopherol polyethylene glycol 1000 succinate-alpha lipoic acid micelles as a potential transdermal drug delivery system: in vitro and ex vivo studies |
title_full |
Optimized vinpocetine-loaded vitamin E D-α-tocopherol polyethylene glycol 1000 succinate-alpha lipoic acid micelles as a potential transdermal drug delivery system: in vitro and ex vivo studies |
title_fullStr |
Optimized vinpocetine-loaded vitamin E D-α-tocopherol polyethylene glycol 1000 succinate-alpha lipoic acid micelles as a potential transdermal drug delivery system: in vitro and ex vivo studies |
title_full_unstemmed |
Optimized vinpocetine-loaded vitamin E D-α-tocopherol polyethylene glycol 1000 succinate-alpha lipoic acid micelles as a potential transdermal drug delivery system: in vitro and ex vivo studies |
title_sort |
optimized vinpocetine-loaded vitamin e d-α-tocopherol polyethylene glycol 1000 succinate-alpha lipoic acid micelles as a potential transdermal drug delivery system: in vitro and ex vivo studies |
publisher |
Dove Medical Press |
publishDate |
2018 |
url |
https://doaj.org/article/927ac8e92e704923aadabbfecaf394fa |
work_keys_str_mv |
AT ahmedoaa optimizedvinpocetineloadedvitaminedalphatocopherolpolyethyleneglycol1000succinatealphalipoicacidmicellesasapotentialtransdermaldrugdeliverysysteminvitroandexvivostudies AT elsaykm optimizedvinpocetineloadedvitaminedalphatocopherolpolyethyleneglycol1000succinatealphalipoicacidmicellesasapotentialtransdermaldrugdeliverysysteminvitroandexvivostudies AT aljaeidbm optimizedvinpocetineloadedvitaminedalphatocopherolpolyethyleneglycol1000succinatealphalipoicacidmicellesasapotentialtransdermaldrugdeliverysysteminvitroandexvivostudies AT badreldinsm optimizedvinpocetineloadedvitaminedalphatocopherolpolyethyleneglycol1000succinatealphalipoicacidmicellesasapotentialtransdermaldrugdeliverysysteminvitroandexvivostudies AT ahmedta optimizedvinpocetineloadedvitaminedalphatocopherolpolyethyleneglycol1000succinatealphalipoicacidmicellesasapotentialtransdermaldrugdeliverysysteminvitroandexvivostudies |
_version_ |
1718399414977953792 |